Ikena Oncology

IPO

Redefining targeted oncology therapies

Public · Boston, United States · Founded 2016 · $195.0M raised

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$195.0M
Last Round
$75.0M Private EquityJul 2025
Rounds
3
Type
Public

About

ImageneBio is a clinical-stage biotechnology company dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases with differentiated clinical profiles. The company is advancing olevaprubart, formerly IMG-007, an anti-OX40 antibody program for atopic dermatitis. Its management team brings decades of experience in R&D and has successfully driven drug candidates through every stage of development and commercialization.

Summary

Ikena Oncology is a Biotech company based in Boston, United States, founded in 2016. It has raised $195.0M in total across 3 rounds, most recently a $75.0M Private Equity round in Jul 2025. Investors include Omega Funds, OrbiMed and Atlas Venture.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Private EquityPrivate EquityJul 2025
$75.0M

Sign up to see all 3 rounds

Series A through Private Equity — per-round amounts, valuations, and who invested in each round.

Investors

Acquisitions

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ikena Oncology on Indexed.vc
<a href="https://indexed.vc/companies/ikena-oncology"><img src="https://indexed.vc/api/badge/company/ikena-oncology" alt="Ikena Oncology on Indexed.vc" width="260" height="76" /></a>